Interleukin-18(IL-18) and Atherosclerosis

被引:0
|
作者
Givtaj, Nozar [1 ]
Bassiri, Hossein Ali [1 ]
Givtaj, Nader [1 ]
Simin, Asghar [1 ]
Noohi, Feridoun [1 ]
机构
[1] Univ Tehran Med Sci, Rajaie Cardiovasc Med & Res Ctr, Tehran, Iran
来源
IRANIAN HEART JOURNAL | 2012年 / 13卷 / 01期
关键词
Inflammation; Atherosclerosis; Interleukin; 18; CAD; Cytokine;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background- Atherosclerosis is a dynamic and progressive disease arising from the combination of endothelial dysfunction and inflammation. So, inflammatory mediators are important causative and progressive factors in atherosclerosis. Interleukin-18 (IL-18) is a pleiotropic cytokine which may have a key role in atherosclerosis, because the results of recent studies indicated that IL-18, either directly as a pro-inflammatory factor or indirectly as an interferon inducing factor, has central role in the inflammatory cascade. In present study, we evaluated the relation between blood concentration of IL-18 with atherosclerosis and its severity and also the relation of this cytokine with the other known risk factors of coronary artery disease (CAD). Methods- 138 patients who underwent diagnostic cardiac catheterization and had the inclusion criteria for this study, were selected. In the beginning, a questionnaire containing personal information and medical history was completed for each of them and blood samples were collected 24 hours before catheterization. We measured blood level of IL-18 and CRP in all samples. The results of these tests and the angiography were entered in the questionnaire and then information was analyzed using regression analyzing, K2 and statistical T test. P values of <0.05 were considered statistically significant. Results- By using the results of angiography, patients were divided in two groups. 1-Control group or normal coronary arteries (32 people) 2- Case group (106 people) or patients who were suffering from CAD. In second group, 6 patients (5.6%) had minimal CAD, 44 patients (41.5%) had single-vessel disease (SVD), 27 patients (25.4%) had 2VD and 29 patients (27.5%) had 3VD. In the laboratory tests, the mean IL-18 blood level in patients with CAD was 258.1 pgr/ml but in normal coronary arteries group it was 216.6 pgr/ml. The average blood level of IL-18 in patients who had minimal CAD was 235.5 pgr/ml, in SVD was 247.2 pgr/ml, in 2VD was 263.7 pgr/ml and in patients with 3VD was 274.1 pgr/ml. Also average CRP blood level in normal group was 8.9 mgr/L while in patients with CAD it was 20.4 mgr/L. Conclusion- The results of this study indicated that there was a direct and significant correlation between blood IL-18 level with existence (P<0.001) and severity of CAD (P<0.01) and IL-18 can be an independent predictor risk factor of atherosclerosis.
引用
收藏
页码:11 / 16
页数:6
相关论文
共 50 条
  • [41] Interleukin 18 (IL-18) Suppresses Thymus Regeneration
    Granadier, David
    Cooper, Kirsten
    Acenas, Dante
    Kinsella, Sinead
    Evandy, Cindy
    Iovino, Lorenzo
    Deroos, Paul
    Hernandez, Vanessa
    Shannon-Sevillano, Steve
    Kousa, Anastasia
    Dudakov, Jarrod
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [42] Blood Interleukin-18 (IL-18) and IL-18 Binding Protein (IL-18BP) Levels Following Midline Laparotomy: A Prospective Randomized Study of Patients With Benign Disease and Patients With Cancer
    Eskelinen, Maaret
    Selander, Tuomas
    Pulkkinen, Jukka
    Haemaelaeinen, Esa
    Eskelinen, Matti
    ANTICANCER RESEARCH, 2024, 44 (05) : 2039 - 2046
  • [43] The Role of Interleukin-18 in the Development and Progression of Atherosclerosis
    Bahrami, Afsane
    Sathyapalan, Thozhukat
    Sahebkar, Amirhossein
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (09) : 1757 - 1774
  • [44] Identification and expression of the product from engineering bacterium containing recombinant human interleukin-18 (IL-18) gene
    Beijing Daxue Xuebao Ziran Kexue Ban/Acta Scientiarum uaturalium Universitatis Pekinensis, 2000, 36 (02): : 271 - 274
  • [45] Influence of methotrexate and steroid-treatment on interleukin-18 (IL-18) expression in patients with rheumatoid arthritis (RA).
    Moeller, B
    Kukoc-Zivojnov, N
    Kessler, U
    Kaltwasser, JP
    Hoelzer, D
    Kalina, U
    Ottmann, OG
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S79 - S79
  • [46] Serum levels of interleukin-18 (IL-18) in patients with juvenile idiopathic arthritis (JIA) and Kawasaki disease (KD).
    Maeno, N
    Takei, S
    Nomura, Y
    Imanaka, H
    Shigemori, M
    Hokonohara, M
    Oda, H
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S472 - S472
  • [47] Urine Interleukin-18 (IL-18) as a Biomarker of Total-Body Irradiation: A Preliminary Study in Nonhuman Primates
    Xiao, Mang
    Bolduc, David L.
    Li, XiangHong
    Cui, Wanchang
    Hieber, Kevin P.
    Bunger, Rolf
    Ossetrova, Natalia I.
    RADIATION RESEARCH, 2017, 188 (03) : 325 - 334
  • [48] Comparison of nucleotide and amino acids sequence of Nilgai (Boselaphus tragocamelus) interleukin-18 (IL-18) with other ruminants
    Das, Dhanjit Kumar
    Saini, Mohini
    Swarup, Devendra
    Gupta, Praveen Kumar
    INDIAN JOURNAL OF BIOTECHNOLOGY, 2008, 7 (02): : 195 - 199
  • [49] PPAR agonist, pioglitazone inhibits interleukin-18 (IL-18)-induced gene expression and apoptosis in cardiac myocytes
    Akagami, Takafumi
    Sakoda, Tsuyoshi
    Doi, Takashi
    Naka, Toshio
    Tsujino, Takeshi
    Masuyama, Tohru
    Ohyanagi, Mitsumasa
    JOURNAL OF CARDIAC FAILURE, 2006, 12 (08) : S162 - S163
  • [50] Interleukin-18 (IL-18)-mediated ischemic acute renal failure (ARF) in mice is neutrophil-independent.
    Melnikov, VY
    Faubel, S
    Ljubanovic, D
    Siegmund, B
    Lucia, SM
    Edelstein, CL
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 31A - 31A